MedPath

DEFYMED

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes

Not Applicable
Recruiting
Conditions
Type 1 Diabetes Mellitus With Hypoglycemia
Type 1 Diabetes
Interventions
Device: ExOlin®
First Posted Date
2022-02-03
Last Posted Date
2022-07-27
Lead Sponsor
Defymed
Target Recruit Count
8
Registration Number
NCT05221359
Locations
🇫🇷

Hôpitaux Universitaires de Strasbourg, Strasbourg, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.